DLTR
31
-3
EMN
50
-5
WDC
50
-2
DG
10
2
WMB
71
3
PVH
65
-3
ESS
65
5
CRM
67
2
CB
50
4
BAX
36
-5
AKAM
40
-22
DE
35
-13
MCD
60
6
JBHT
68
3
JWN
50
-2
NRG
75
-2
NOC
54
4
CF
48
-5
KMI
81
2
NI
68
5
DLTR
31
-3
EMN
50
-5
WDC
50
-2
DG
10
2
WMB
71
3
PVH
65
-3
ESS
65
5
CRM
67
2
CB
50
4
BAX
36
-5
AKAM
40
-22
DE
35
-13
MCD
60
6
JBHT
68
3
JWN
50
-2
NRG
75
-2
NOC
54
4
CF
48
-5
KMI
81
2
NI
68
5
Financhill
Back

BioXcel Therapeutics Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
44

BTAI
BioXcel Therapeutics

Last Price:
0.67
Seasonality Move:
80.1%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

BioXcel Therapeutics Price Quote

$0.67
-0.01 (-0.01%)
(Updated: November 9, 2024 at 5:16 AM ET)

BioXcel Therapeutics Key Stats

Sell
44
BioXcel Therapeutics (BTAI) is a Sell
Day range:
$0.65 - $0.69
52-week range:
$0.51 - $5.62
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
9.18
P/B ratio:
0%
Volume:
292K
Avg. volume:
375.5K
1-year change:
-85.41%
Market cap:
$27.7M
Revenue:
$1.4M
EPS:
$-3.56

How Much Does BioXcel Therapeutics Make?

Is BioXcel Therapeutics Growing As A Company?

  • What Is BioXcel Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.42%
  • What Is BioXcel Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

BioXcel Therapeutics Stock Price Performance

What Is BioXcel Therapeutics 52-Week High & Low?

BioXcel Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy BioXcel Therapeutics?

Is BioXcel Therapeutics Cash Flow Positive?

  • What Is BTAI Cash Flow From Operations?
    Cash flow from operations (TTM) is -$105.3M
  • What Is BioXcel Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $34.1M
  • What Is BioXcel Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

BioXcel Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    BTAI return on invested capital is -204.8%
  • What Is BioXcel Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -116.7%
  • What Is BTAI Return On Equity?
    ROE is a measure of profitability and is 0%

BioXcel Therapeutics Earnings Date & Stock Price

BioXcel Therapeutics Competitors

BioXcel Therapeutics Dividend Yield

BioXcel Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 69.42%
Revenue: 141.58% 0.36%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 4.20
Upside from Last Price: 517.65%

Major Shareholders

  • How many BTAI shares are owned by institutional investors?
    21.6M BTAI shares are owned by institutional investors
  • How many BTAI shares are owned by insiders?
    282.4K BTAI shares are owned by insiders